Issue · Healthcare

Healthcare (Medicare)

Every healthcare bill, vote, and legislator stance in United States, automatically classified by Maddy, our AI policy reader.

Total bills
550
119th Congress
Top supporter
Christopher Murphy
88% support rate
Top opponent
Bill Hagerty
12% support rate
Ranked legislators
10
5 support · 5 oppose
Key legislators

Who's moving medicare in United States

Legislators moving medicare in United States
Legislator Party Stance Support rate Decisive votes
Christopher Murphy
Christopher Murphy Senate
D
Strong +
88% 8
Adam B. Schiff
Adam B. Schiff Senate
D
Support
78% 9
Alex Padilla
Alex Padilla Senate
D
Support
78% 9
Amy Klobuchar
Amy Klobuchar Senate
D
Support
78% 9
Andy Kim
Andy Kim Senate
D
Support
78% 9
Bill Hagerty
Bill Hagerty Senate
R
Strong −
12% 8
Mitch McConnell
Mitch McConnell Senate
R
Strong −
12% 8
Roger F. Wicker
Roger F. Wicker Senate
R
Strong −
12% 8
Jerry Moran
Jerry Moran Senate
R
Strong −
14% 7
Ashley Moody
Ashley Moody Senate
R
Oppose
22% 9
Showing 261–270 of 550 bills

All healthcare bills

in committee · United States · House Oct 10, 2025

HR 5736: PAVE Act

HR 5736, the PAVE Act, requires Medicare beneficiaries aged 65 and older to receive penicillin allergy verification during their initial preventive physical exam and annual wellness visit. The bill mandates that healthcare providers identify patients reporting a penicillin allergy, evaluate whether the reported reaction was a true allergy, explain the health risks of a false allergy label, and refer to specialists when needed. This verification process, effective January 2027, aims to correct false allergy labels - over 90% of which are inaccurate - improving antibiotic choices and patient outcomes. It directly affects seniors covered by Medicare who have self-reported penicillin allergies, with no cost to patients for this service.
Sub-Topics Medicare
in committee · United States · House Mar 18, 2025

HR 2191: Physician Led and Rural Access to Quality Care Act

This bill modifies Medicare's physician self-referral rules to improve access for rural communities. It creates a new exemption for "covered rural hospitals" (defined as facilities in rural areas more than 35 miles from another hospital or critical access hospital) from certain restrictions on physicians owning hospitals. The bill also removes a prohibition on expanding existing physician-owned hospitals, allowing such expansions after the law's enactment. These changes directly affect rural hospitals seeking Medicare participation and physicians who own or operate hospitals in underserved areas.
in committee · United States · House Mar 10, 2025

HR 2005: DMEPOS Relief Act of 2025

This bill extends current Medicare payment rates for durable medical equipment (like wheelchairs and oxygen) in non-rural areas through December 2025. It delays implementing a new payment rule for all areas until January 2026. The law directly affects Medicare beneficiaries needing equipment and the suppliers who provide it by maintaining existing reimbursement rates for an additional year. This avoids immediate payment reductions for non-rural areas while postponing the full transition to new rates.
Sub-Topics Medicare
in committee · United States · House May 7, 2025

HR 3263: PATCH Act

HR 3263, the PATCH Act, modifies Medicare payment rules for physicians in Hawaii. It requires the Medicare program to set a minimum payment adjustment factor of 1.5 for physician services provided in Hawaii starting January 1, 2026, if the standard calculation would result in a lower value. This change directly affects Medicare-reimbursed physicians and healthcare providers operating in Hawaii. The key mechanism is a floor on the "work geographic index," ensuring payments in Hawaii do not fall below this minimum level. The provision applies specifically to services furnished in Hawaii after 2025.
Sub-Topics Medicare
in committee · United States · House Feb 26, 2025

HR 1616: Promoting Access to Diabetic Shoes Act

This bill amends Medicare rules to allow nurse practitioners and physician assistants to certify diabetic shoe coverage for Medicare beneficiaries with diabetes, expanding the current requirement that only physicians could provide this documentation. It directly affects Medicare patients needing specialized footwear due to diabetes and healthcare providers like NPs and PAs who would now be authorized to meet the certification requirement. The key change modifies Section 1861(s)(12) of the Social Security Act to insert "nurse practitioner, or physician assistant" in all relevant sections of the documentation rules. This update simplifies access to covered diabetic shoes by broadening which healthcare professionals can issue the necessary certification.
in committee · United States · House Jan 3, 2025

HR 193: Maintaining Innovation and Safe Technologies Act

The Maintaining Innovation and Safe Technologies Act requires the U.S. Department of Health and Human Services to issue Medicare Part B payment guidance by January 1, 2027, for remote monitoring devices that use artificial intelligence. This guidance will clarify payment rules for devices like continuous glucose monitors, which must have an AI component (e.g., automatic adjustments) and transmit patient data to healthcare providers for treatment management. The bill directly affects Medicare coverage for these AI-enabled medical devices, used by patients managing chronic conditions such as diabetes. It does not change current reimbursement rates but mandates clear payment criteria through updated guidance by the specified deadline.
in committee · United States · Senate Jan 24, 2025

S 247: Choices for Increased Mobility Act of 2025

This bill requires Medicare to create separate billing codes for ultralightweight manual wheelchairs based on their frame material (e.g., titanium/carbon fiber vs. other materials) starting in 2026. It directly affects Medicare beneficiaries who use these wheelchairs, particularly those purchasing or renting models with titanium or carbon fiber frames. The bill mandates that Medicare pays suppliers the standard rate for such wheelchairs regardless of material, but allows suppliers to charge beneficiaries the difference between that payment and their actual cost. It also requires suppliers to provide clear financial notices to patients before sale or rental to inform them of potential additional costs.
Sub-Topics Medicaid Medicare
in committee · United States · House Mar 5, 2026

HR 7837: Most Favored Patient Act of 2026

This bill requires drug manufacturers to offer Medicare Part D and Part B patients the lowest price they charge in eight specific countries (Canada, Denmark, France, Germany, Italy, Japan, Switzerland, UK), defined as the "most-favored-nation price." It directly affects drug manufacturers not in a special agreement with Medicare and Medicare beneficiaries who use covered drugs. The model, tested for five years starting in 2029, mandates manufacturers to report pricing data and provide discounts to eligible patients and providers. Manufacturers could avoid the requirement by signing an agreement with Medicare before December 2028. The bill aims to align U.S. drug prices with international averages for certain Medicare-covered drugs.
in committee · United States · House Mar 18, 2025

HR 2199: Restore Protections for Dialysis Patients Act

This bill (HR 2199) prevents private health insurance plans from discriminating against patients with end-stage kidney disease (ESRD) who require dialysis. It amends the Social Security Act to prohibit plans from treating dialysis coverage differently than other medical services or applying network restrictions that disproportionately harm ESRD patients. The law clarifies that plans cannot deny or limit benefits for dialysis based on a patient’s diagnosis, while preserving a plan’s right to choose which dialysis providers are in their network. It directly affects ESRD patients and their private health insurance coverage, ensuring dialysis is treated equally with other covered medical services. The bill does not require plans to include specific dialysis providers but stops them from unfairly restricting access to necessary care.
Sub-Topics Insurance Medicare
in committee · United States · Senate Feb 25, 2025

S 717: Increasing Access to Quality Cardiac Rehabilitation Care Act of 2025

S 717, the *Increasing Access to Quality Cardiac Rehabilitation Care Act of 2025*, expands Medicare coverage for cardiac and pulmonary rehabilitation programs by broadening which healthcare providers can prescribe these services. The bill amends Medicare rules to allow physician assistants, nurse practitioners, and clinical nurse specialists (in addition to physicians) to prescribe exercise and rehabilitation programs under Medicare Part B. This change directly affects Medicare beneficiaries requiring cardiac or pulmonary rehab, making it easier to access care from a wider range of qualified providers. The key provision removes restrictive language limiting prescriptions to "physicians" and updates definitions to include these additional provider types, effective six months after enactment.
Showing 261 to 270 of 550 bills
Previous 1 … 26 27 28 … 55 Next